Block (ASX:SQ2) attacked by a short-seller

Nick Sundich Nick Sundich, March 24, 2023

Jack Dorsey-led fintech Block (ASX:SQ2) has been attacked by short-seller Hindenburg Research.

Hindenburg has essentially alleged the entire company is a fraud while SQ2 has predictably denied the allegations and threatened legal action, as most companies in this position do. 

 

No time to do stock research, but you still want to invest?

 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 
Hindenburg’s allegations

Hindenburg Research claimed to have conducted a 2-year investigation into the company, interviewing former employees and industry experts, reviewing regulatory and litigation records and financial modelling. 

Among its allegations were that it overstated its user counts, understated customer acquisition costs and failed to take action against criminal activity being done using the app. 

The report led to the company’s shares falling over 16% this morning. It debuted on the ASX in February 2022 after acquiring Afterpay.  

 

Block (ASX:SQ2) share price chart, log scale (Source: TradingView)

 

Block response

The company released a short statement on its website in which it denied the allegations and said it would explore legal action against Hindenburg.

‘We are a highly regulated public company with regular disclosures, and are confident in our products, reporting, compliance programs, and controls,’ it said. 

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
 
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

best stocks

5 Best Stocks Under $100 To Buy Now

If you’re new to investing and don’t have a lot of money to start with, will you be missing out…

Telix Pharmaceuticals on the Nasdaq

Telix Pharmaceuticals (ASX:TLX): Is there further upside to be excited for in FY25?

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…

like for like sales

Like for like sales: What does it mean and why do retailers use that creative term?

ASX retailers often use ‘like for like’ sales in addition to total sales. It is most common for companies that…